Inflammasome Therapeutics
Newton
About Inflammasome Therapeutics
Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.2M
- Last round: Series Unknown (Mar 2025)
- Website: inflam.com
- Phone: 617-331-1071
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/inflammasome-therapeutics-83851 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.